AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

It's a threat that will send a shiver down the spine of Downing Street and shake the City of London to its core..

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

(Reuters) -AstraZeneca chief executive Pascal Soriot is considering moving the company's stock market listing to the United ...

In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...

The government must urgently abolish stamp duty on shares and abolish new cash ISAs to prevent the London Stock Exchange losing it’s most valuable listing, Astrazeneca, says Michael Healy The UK stock ...

Cambridge UK Pharma giant AstraZeneca is proving a variation on the proverbial enigma as it ponders the most appreciative ...

HSBC and Shell are the only two British companies in the top 100 of Forbes’ Global 2000, but its presence grows with 68 scattered throughout the list.